Related Experiment Video
Updated: May 12, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Thrombospondin in colorectal disease
1Department of Medicine, University of Manchester, Manchester, UK, Department Pathological Sciences, University of Manchester, Manchester, UK, Department of Pathology, University Hospital of South Manchester, Manchester, UK.
Thrombospondin (TSP) is present in various colon diseases but not in healthy tissue. Its presence in colorectal cancer does not correlate with patient survival, suggesting it indicates general disease rather than specific cancer progression.
Area of Science:
- Oncology
- Gastroenterology
- Immunohistochemistry
Background:
- Thrombospondin (TSP) is a protein with diverse biological functions.
- Its role in colorectal disease and cancer progression requires further investigation.
Purpose of the Study:
- To evaluate the presence of TSP in normal colonic tissue and various colonic diseases, including colorectal cancer.
- To determine if TSP expression correlates with survival outcomes in patients with colorectal cancer.
Main Methods:
- Immunohistochemical staining using a specific TSP antibody on paraffin-embedded human colorectal tissue samples.
- Analysis included 103 carcinomas, 10 inflammatory bowel disease (IBD) cases, 10 diverticulosis cases, and 10 normal controls.
- Quantitative assessment of TSP staining intensity was performed using a computer-assisted image analysis system.
Main Results:
- TSP staining was detected in 73% of colorectal carcinomas, 30% of IBD specimens, and 80% of diverticulosis specimens.
- No TSP staining was observed in any of the normal colonic tissue samples.
- No statistically significant correlation was found between TSP expression levels and patient survival in colorectal cancer.
Conclusions:
- The presence of TSP in the colon is not specific to colorectal cancer and is indicative of an underlying disease process.
- TSP expression does not serve as a prognostic biomarker for survival in colorectal cancer patients.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Diverticular Disease of the Colon
Venous Thrombosis I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
